Commercial 5-Fluoro-2-Cyanopyridine Bulk Price 2026: Market Analysis & Sourcing Guide
- [Chemical Engineering]: Optimized halogen exchange yields consistently exceed 95% assay purity.
- [Procurement Logic]: Factory-direct lead times reduced to under 4 weeks for tonnage quantities.
- [Strategic Sourcing]: Full REACH/TSCA compliance documentation available for global export.
The demand for fluorinated heterocycles continues to surge as pharmaceutical and agrochemical pipelines expand into 2026. Specifically, the Commercial 5-Fluoro-2-Cyanopyridine Bulk Price 2026 forecast indicates a stabilization in costs driven by improved manufacturing scalability. As a critical Heterocyclic building block, this compound is essential for the synthesis of kinase inhibitors and advanced crop protection agents. Procurement teams must navigate the shift from research-grade pricing to commercial-scale economics to secure cost-effective supply chains.
For organizations evaluating long-term contracts, understanding the technical nuances of the manufacturing process is vital. Unlike smaller suppliers who rely on toll manufacturing, established entities maintain strict control over the synthesis route to ensure batch-to-batch consistency. This control directly impacts the bulk price stability, mitigating risks associated with raw material volatility in the fluorine chemistry sector.
Technical Specifications and Process Chemistry
From a process chemistry perspective, the production of 5-Fluoro-2-cyanopyridine requires precise control over halogen exchange reactions. The primary challenge lies in minimizing defluorination side products and ensuring the nitrile group remains intact during high-temperature steps. High-performance liquid chromatography (HPLC) analysis typically targets an assay of 97% or higher for pharmaceutical applications, whereas industrial purity standards for agrochemicals may accept 95% provided specific impurity profiles are managed.
The following table outlines the critical quality parameters expected from a tier-1 supplier:
| Parameter | Specification | Test Method |
|---|---|---|
| CAS Number | 327056-62-2 | N/A |
| Chemical Name | 2-Cyano-5-fluoropyridine | IUPAC |
| Molecular Formula | C6H3FN2 | N/A |
| Molecular Weight | 122.1 g/mol | Calculated |
| Purity (Assay) | ≥ 97.0% (Pharma Grade) | HPLC / GC |
| Melting Point | 35-41 °C | DSC / Capillary |
| Physical Form | Solid (Off-white to White) | Visual |
When scaling this Fluorinated pyridine derivative, impurity profiling becomes paramount. Process chemists must verify the absence of residual chloro-precursors and heavy metals. Sourcing from a global manufacturer with in-process quality control ensures that the 2-Cyano-5-fluoropyridine delivered meets stringent pharmacopeial standards without requiring extensive downstream purification.
Supply Chain Stability and Volume Economics
Procurement officers often face lead times ranging from 4 to 6 weeks when ordering from distributors who hold limited stock. However, direct engagement with the production facility allows for better planning around campaign schedules. For buyers requiring custom synthesis or modified packaging, early engagement is necessary to align with production slots. The cost per kilogram drops significantly when moving from gram-scale research quantities to multi-kilogram or tonne-scale orders.
Transparency in documentation is another key factor. Reliable suppliers provide comprehensive COA and MSDS packages with every shipment. This documentation is critical for customs clearance and internal quality assurance audits. When sourcing high-purity 5-Fluoropyridine-2-carbonitrile, buyers should verify that the Certificate of Analysis includes detailed impurity lists rather than just a general purity percentage.
Executive Outlook: Compliance and Scalability
For executive leadership, the decision to qualify a new supplier hinges on regulatory compliance and commercial viability. NINGBO INNO PHARMCHEM CO.,LTD. operates with a focus on regulatory adherence, ensuring that all exports meet international safety standards including REACH and TSCA requirements. This reduces the liability burden on the purchasing organization and facilitates smoother market entry for finished products.
Looking toward 2026, the market for pyridine intermediates is expected to remain robust. Securing a primary supply partner now mitigates the risk of future capacity constraints. NINGBO INNO PHARMCHEM CO.,LTD. offers the technical expertise and production capacity required to support large-scale API manufacturing, ensuring that your supply chain remains resilient against global disruptions.
Request a Formal Quote
To discuss volume discount tiers, verify current stock levels, or request a batch-specific COA, SDS, or bulk pricing quote, please contact our technical sales team directly. We are prepared to support your R&D and commercial production needs with reliable, high-quality intermediates.